{"id":46937,"date":"2022-08-04T15:02:09","date_gmt":"2022-08-04T13:02:09","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/"},"modified":"2022-08-04T15:02:09","modified_gmt":"2022-08-04T13:02:09","slug":"trinity-life-sciences-acquires-vancerys-customer-research-technology","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/","title":{"rendered":"Trinity Life Sciences Acquires Vancery\u2019s Customer Research Technology"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<b><i>Asset Acquisition Enables Trinity to Better Connect with Healthcare Professionals<\/i><\/b>\n<\/p>\n<p>WALTHAM, Mass.&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftrinitylifesciences.com%2F&amp;esheet=52800722&amp;newsitemid=20220804005069&amp;lan=en-US&amp;anchor=Trinity+Life+Sciences&amp;index=1&amp;md5=fc4f9c22d083c6a41aff0cb20377cb60\" rel=\"nofollow noopener\" shape=\"rect\">Trinity Life Sciences<\/a>, a leader in global life sciences commercialization solutions, announced it signed an asset purchase agreement for the acquisition of <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vancery.com%2F&amp;esheet=52800722&amp;newsitemid=20220804005069&amp;lan=en-US&amp;anchor=Vancery%26%238217%3Bs&amp;index=2&amp;md5=74c8d8c5ba64a347807a7e5b49c73add\" rel=\"nofollow noopener\" shape=\"rect\">Vancery\u2019s<\/a> customer research technology. The investment expands Trinity\u2019s insights and analytics product offerings, allowing the company to better connect with healthcare professionals to inform commercial strategy for its clients. The new technology will improve primary market research in the life sciences by integrating advanced research methods with an enhanced respondent experience to drive higher quality insights.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220804005069\/en\/775019\/5\/trinity-logo-530_x_146.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220804005069\/en\/775019\/21\/trinity-logo-530_x_146.jpg\"><\/a><\/p>\n<p>\n\u201cWe are thrilled to bring the sophisticated customer research technology that Vancery built to the healthcare space,\u201d said <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fdeshpandeaparna%2F&amp;esheet=52800722&amp;newsitemid=20220804005069&amp;lan=en-US&amp;anchor=Aparna+Deshpande&amp;index=3&amp;md5=f8c3fd6a46232ad6c18875fd2571d221\" rel=\"nofollow noopener\" shape=\"rect\">Aparna Deshpande<\/a>, PhD, Senior Partner, Insights. \u201cNow, more than ever, payer, patient and healthcare provider research are critical in making sure treatments are available ASAP to those in need.\u201d\n<\/p>\n<p>\nBesides the technology acquisition, a team of experts from Vancery will join Trinity to continue to support and transform the software for use in healthcare.\n<\/p>\n<p>\n\u201cI am so proud of what the Vancery team has built and delighted that Trinity will bring our technology and vision to the next level,\u201d said <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fgunnargregory%2F&amp;esheet=52800722&amp;newsitemid=20220804005069&amp;lan=en-US&amp;anchor=Gunnar+Gregory&amp;index=4&amp;md5=a4a9f6ce1f6b616dcb5b57972a11c226\" rel=\"nofollow noopener\" shape=\"rect\">Gunnar Gregory<\/a>, CEO, Vancery. \u201cWith Trinity, our unique technologies will help incorporate qualitative and quantitative research into their life science clients\u2019 daily decision-making.\u201d\n<\/p>\n<p>\n<b>About Trinity Life Sciences<\/b>\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.trinitylifesciences.com&amp;esheet=52800722&amp;newsitemid=20220804005069&amp;lan=en-US&amp;anchor=Trinity+Life+Sciences&amp;index=5&amp;md5=d25c67c37679c81e1f5c0f5b1eff7242\" rel=\"nofollow noopener\" shape=\"rect\">Trinity Life Sciences<\/a> is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With over 25 years of experience, Trinity is committed to solving clients\u2019 most challenging problems through exceptional levels of service, powerful tools and data-driven insights. Trinity\u2019s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity revolutionizing the commercial model, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftrinitylifesciences.com%2F&amp;esheet=52800722&amp;newsitemid=20220804005069&amp;lan=en-US&amp;anchor=trinitylifesciences.com&amp;index=6&amp;md5=5289f59e34fa4f4cd286763d8e06d11f\" rel=\"nofollow noopener\" shape=\"rect\">trinitylifesciences.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nElizabeth Marshall<br \/>\n<br \/>Trinity Life Sciences<br \/>\n<br \/>781-577-6376<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;lt&#x6f;&#x3a;&#101;&#109;a&#x72;&#x73;&#104;&#97;l&#x6c;&#x40;&#x74;&#114;in&#x69;&#x74;&#121;&#108;i&#x66;&#x65;&#115;&#99;i&#x65;&#x6e;&#99;&#101;s&#x2e;&#x63;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#101;&#x6d;&#97;&#x72;&#115;&#x68;a&#x6c;l&#64;&#x74;&#114;&#x69;&#110;&#x69;t&#x79;l&#105;&#x66;&#101;&#x73;&#99;&#x69;&#101;&#x6e;c&#x65;s&#46;&#x63;&#111;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Asset Acquisition Enables Trinity to Better Connect with Healthcare Professionals WALTHAM, Mass.&#8211;(BUSINESS WIRE)&#8211;Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced it signed an asset purchase agreement for the acquisition of Vancery\u2019s customer research technology. The investment expands Trinity\u2019s insights and analytics product offerings, allowing the company to better connect with healthcare &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46937","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Trinity Life Sciences Acquires Vancery\u2019s Customer Research Technology - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Trinity Life Sciences Acquires Vancery\u2019s Customer Research Technology - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Asset Acquisition Enables Trinity to Better Connect with Healthcare Professionals WALTHAM, Mass.&#8211;(BUSINESS WIRE)&#8211;Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced it signed an asset purchase agreement for the acquisition of Vancery\u2019s customer research technology. The investment expands Trinity\u2019s insights and analytics product offerings, allowing the company to better connect with healthcare ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-04T13:02:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220804005069\/en\/775019\/21\/trinity-logo-530_x_146.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trinity-life-sciences-acquires-vancerys-customer-research-technology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trinity-life-sciences-acquires-vancerys-customer-research-technology\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Trinity Life Sciences Acquires Vancery\u2019s Customer Research Technology\",\"datePublished\":\"2022-08-04T13:02:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trinity-life-sciences-acquires-vancerys-customer-research-technology\\\/\"},\"wordCount\":308,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trinity-life-sciences-acquires-vancerys-customer-research-technology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220804005069\\\/en\\\/775019\\\/21\\\/trinity-logo-530_x_146.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trinity-life-sciences-acquires-vancerys-customer-research-technology\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trinity-life-sciences-acquires-vancerys-customer-research-technology\\\/\",\"name\":\"Trinity Life Sciences Acquires Vancery\u2019s Customer Research Technology - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trinity-life-sciences-acquires-vancerys-customer-research-technology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trinity-life-sciences-acquires-vancerys-customer-research-technology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220804005069\\\/en\\\/775019\\\/21\\\/trinity-logo-530_x_146.jpg\",\"datePublished\":\"2022-08-04T13:02:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trinity-life-sciences-acquires-vancerys-customer-research-technology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trinity-life-sciences-acquires-vancerys-customer-research-technology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trinity-life-sciences-acquires-vancerys-customer-research-technology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220804005069\\\/en\\\/775019\\\/21\\\/trinity-logo-530_x_146.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220804005069\\\/en\\\/775019\\\/21\\\/trinity-logo-530_x_146.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trinity-life-sciences-acquires-vancerys-customer-research-technology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Trinity Life Sciences Acquires Vancery\u2019s Customer Research Technology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Trinity Life Sciences Acquires Vancery\u2019s Customer Research Technology - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/","og_locale":"en_US","og_type":"article","og_title":"Trinity Life Sciences Acquires Vancery\u2019s Customer Research Technology - Pharma Trend","og_description":"Asset Acquisition Enables Trinity to Better Connect with Healthcare Professionals WALTHAM, Mass.&#8211;(BUSINESS WIRE)&#8211;Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced it signed an asset purchase agreement for the acquisition of Vancery\u2019s customer research technology. The investment expands Trinity\u2019s insights and analytics product offerings, allowing the company to better connect with healthcare ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-04T13:02:09+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220804005069\/en\/775019\/21\/trinity-logo-530_x_146.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Trinity Life Sciences Acquires Vancery\u2019s Customer Research Technology","datePublished":"2022-08-04T13:02:09+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/"},"wordCount":308,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220804005069\/en\/775019\/21\/trinity-logo-530_x_146.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/","url":"https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/","name":"Trinity Life Sciences Acquires Vancery\u2019s Customer Research Technology - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220804005069\/en\/775019\/21\/trinity-logo-530_x_146.jpg","datePublished":"2022-08-04T13:02:09+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220804005069\/en\/775019\/21\/trinity-logo-530_x_146.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220804005069\/en\/775019\/21\/trinity-logo-530_x_146.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/trinity-life-sciences-acquires-vancerys-customer-research-technology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Trinity Life Sciences Acquires Vancery\u2019s Customer Research Technology"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46937","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46937"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46937\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46937"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46937"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46937"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}